339 related articles for article (PubMed ID: 25503724)
1. Vitamin D receptor agonist VS-105 improves cardiac function in the presence of enalapril in 5/6 nephrectomized rats.
Wu-Wong JR; Chen YW; Wessale JL
Am J Physiol Renal Physiol; 2015 Feb; 308(4):F309-19. PubMed ID: 25503724
[TBL] [Abstract][Full Text] [Related]
2. VS-105: a novel vitamin D receptor modulator with cardiovascular protective effects.
Wu-Wong JR; Kawai M; Chen YW; Nakane M
Br J Pharmacol; 2011 Sep; 164(2b):551-60. PubMed ID: 21557735
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D receptor agonist VS-105 directly modulates parathyroid hormone expression in human parathyroid cells and in 5/6 nephrectomized rats.
Sawada K; Wu-Wong JR; Chen YW; Wessale JL; Kanai G; Kakuta T; Fukagawa M
J Steroid Biochem Mol Biol; 2017 Mar; 167():48-54. PubMed ID: 27989797
[TBL] [Abstract][Full Text] [Related]
4. Two novel vitamin D receptor modulators with similar structures exhibit different hypercalcemic effects in 5/6 nephrectomized uremic rats.
Wu-Wong JR; Kawai M; Chen YW; Wessale JL; Huang CJ; Wu MT; Nakane M
Am J Nephrol; 2013; 37(4):310-9. PubMed ID: 23548814
[TBL] [Abstract][Full Text] [Related]
5. Cardiac effect of vitamin D receptor modulators in uremic rats.
Mizobuchi M; Ogata H; Yamazaki-Nakazawa A; Hosaka N; Kondo F; Koiwa F; Kinugasa E; Shibata T
J Steroid Biochem Mol Biol; 2016 Oct; 163():20-7. PubMed ID: 27072785
[TBL] [Abstract][Full Text] [Related]
6. Hypertension and Organ Damage in Women.
Muiesan ML; Paini A; Aggiusti C; Bertacchini F; Rosei CA; Salvetti M
High Blood Press Cardiovasc Prev; 2018 Sep; 25(3):245-252. PubMed ID: 29943358
[TBL] [Abstract][Full Text] [Related]
7. Intestinal inhibition of the Na+/H+ exchanger 3 prevents cardiorenal damage in rats and inhibits Na+ uptake in humans.
Spencer AG; Labonte ED; Rosenbaum DP; Plato CF; Carreras CW; Leadbetter MR; Kozuka K; Kohler J; Koo-McCoy S; He L; Bell N; Tabora J; Joly KM; Navre M; Jacobs JW; Charmot D
Sci Transl Med; 2014 Mar; 6(227):227ra36. PubMed ID: 24622516
[TBL] [Abstract][Full Text] [Related]
8. Treatment with enalapril and not diltiazem ameliorated progression of chronic kidney disease in rats, and normalized renal AT1 receptor expression as measured with PET imaging.
Ismail B; deKemp RA; Croteau E; Hadizad T; Burns KD; Beanlands RS; DaSilva JN
PLoS One; 2017; 12(5):e0177451. PubMed ID: 28542215
[TBL] [Abstract][Full Text] [Related]
9. Chronic urocortin 2 administration improves cardiac function and ameliorates cardiac remodeling after experimental myocardial infarction.
Ellmers LJ; Scott NJ; Cameron VA; Richards AM; Rademaker MT
J Cardiovasc Pharmacol; 2015 Mar; 65(3):269-75. PubMed ID: 25658462
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin combined with ACE inhibitor prevents heart remodeling in 5/6 nephrectomized rats independently of blood pressure and kidney function.
Gut N; Piecha G; Aldebssi F; Schaefer S; Bekeredjian R; Schirmacher P; Ritz E; Gross-Weissmann ML
Am J Nephrol; 2013; 38(2):124-35. PubMed ID: 23920063
[TBL] [Abstract][Full Text] [Related]
11. Chronic kidney disease: cardiac and renal angiotensin-converting enzyme (ACE) 2 expression in rats after subtotal nephrectomy and the effect of ACE inhibition.
Burrell LM; Burchill L; Dean RG; Griggs K; Patel SK; Velkoska E
Exp Physiol; 2012 Apr; 97(4):477-85. PubMed ID: 22198016
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of VS-105: A novel and potent vitamin D receptor agonist with reduced hypercalcemic effects.
Chen B; Kawai M; Wu-Wong JR
Bioorg Med Chem Lett; 2013 Nov; 23(21):5949-52. PubMed ID: 24035340
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of vitamin D receptor activators on aortic calcification and pulse wave velocity in uraemic rats.
Noonan W; Koch K; Nakane M; Ma J; Dixon D; Bolin A; Reinhart G
Nephrol Dial Transplant; 2008 Dec; 23(12):3824-30. PubMed ID: 18644798
[TBL] [Abstract][Full Text] [Related]
14. Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone Improves Diastolic Dysfunction in Preclinical Nondiabetic Chronic Kidney Disease.
Lima Posada I; Soulié M; Stephan Y; Palacios Ramirez R; Bonnard B; Nicol L; Pitt B; Kolkhof P; Mulder P; Jaisser F
J Am Heart Assoc; 2024 Jun; 13(12):e032971. PubMed ID: 38842271
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D receptor activation, left ventricular hypertrophy and myocardial fibrosis.
Panizo S; Barrio-Vázquez S; Naves-Díaz M; Carrillo-López N; Rodríguez I; Fernández-Vázquez A; Valdivielso JM; Thadhani R; Cannata-Andía JB
Nephrol Dial Transplant; 2013 Nov; 28(11):2735-44. PubMed ID: 24013683
[TBL] [Abstract][Full Text] [Related]
16. Enalapril in subantihypertensive dosage attenuates kidney proliferation and functional recovery in normotensive ablation nephropathy of the rat.
Krivosíková Z; Sebeková K; Spustová V; Lajdová I; Dzúrik R
Physiol Res; 1999; 48(6):429-35. PubMed ID: 10783907
[TBL] [Abstract][Full Text] [Related]
17. Different vitamin D receptor agonists exhibit differential effects on endothelial function and aortic gene expression in 5/6 nephrectomized rats.
Wu-Wong JR; Li X; Chen YW
J Steroid Biochem Mol Biol; 2015 Apr; 148():202-9. PubMed ID: 25500070
[TBL] [Abstract][Full Text] [Related]
18. The nitric oxide donor molsidomine rescues cardiac function in rats with chronic kidney disease and cardiac dysfunction.
Bongartz LG; Braam B; Verhaar MC; Cramer MJ; Goldschmeding R; Gaillard CA; Steendijk P; Doevendans PA; Joles JA
Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H2037-45. PubMed ID: 20852057
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats.
Mizobuchi M; Morrissey J; Finch JL; Martin DR; Liapis H; Akizawa T; Slatopolsky E
J Am Soc Nephrol; 2007 Jun; 18(6):1796-806. PubMed ID: 17513326
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of NHE3-mediated Sodium Absorption in the Gut Reduced Cardiac End-organ Damage Without Deteriorating Renal Function in Obese Spontaneously Hypertensive Rats.
Linz B; Hohl M; Reil JC; Böhm M; Linz D
J Cardiovasc Pharmacol; 2016 Mar; 67(3):225-31. PubMed ID: 26727380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]